Evidence map›Paper›PMID 34898356›Full record

ArticleBioengineered2022

Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway.

Lei Sun, Hua Wang, Dan Xu, Shanshan Yu, Lin Zhang, Xiaopeng Li

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Ferroptosis: a new target for depression prevention and treatment.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Autophagy · 2025
    Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lei SunUltrasonic Department, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Hua WangUltrasonic Department, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Dan XuUltrasonic Department, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Shanshan YuUltrasonic Department, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Lin ZhangUltrasonic Department, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Xiaopeng LiUltrasonic Department, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Second Affiliated Hospital of Xi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lapatinib (LAP) is an important anti-cancer drug and is frequently alongside doxorubicin (DOX) as a combination therapy for better anti-cancer efficacy. However, many studies have reported that LAP in combination with DOX may induce highly cardiotoxicity. Accordingly, we aimed to explore the potential mechanism involved in the synergistic effect of LAP in DOX-induced cardiotoxicity. Here, cell counting kit-8 was used to detect cell viability and lactate dehydrogenase measurement was performed to assess cell injury. Cell apoptosis was evaluated by TUNEL assay and western blot assay. Mitochondrial dysfunction was identified by JC-1 assay, adenosine triphosphate (ATP) and Cytochrome C. Moreover, the activity of ROS, SOD, CAT and GSH were measured to elucidate oxidative stress level. Ferroptosis was examined by levels of Fe

Indexed as

FerroptosisAnimalsCell LineCell SurvivalDose-Response Relationship, DrugDoxorubicinDrug SynergismGene Expression RegulationLapatinibMitochondriaMyocytes, CardiacOxidative StressPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRatsSignal TransductionDoxorubicinLapatinibPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktcardiomyocytesdoxorubicinferroptosisLapatinibmitochondrial dysfunctionPI3K/AKT signaling pathway

Identifiers

PMID34898356
PMCPMC8805895
OpenAlexW4200335207

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.